- A further precipitous tariff hike and earlier implementation timeline announced by the US authority on China’s medical-grade gloves are poised to revitalise investors’ sentiment on the Malaysian glove sector.
- With the sector’s post-pandemic recovery eclipsing earnings amid demand moderation, domestic glovemakers should progressively reclaim market share from China, sustaining concrete ASP trajectories and margin upticks. Maintain OVERWEIGHT.
US imposed higher tariff and earlier timeline on China medical-grade gloves in modifications of statutory review.
- - Read this at SGinvestors.io -
- The modified tariff action includes higher tariff of 50% in 2025 and 100% in 2026 (from current 7.5%; initially proposed 25% in 2026) on China’s rubber medical and surgical gloves’ exports into the US beginning next year.
Structural change likely altering nitrile gloves’ demand landscapes.
- - Read this at SGinvestors.io -
- To note, China had significantly raised its global market share from around 11% in 2019 to >30% in 2023. While China players predominantly produce PVC vinyl and nitrile gloves (>85% of total sales in 2023), we assess meaningful nitrile gloves demand flowing back to Malaysian manufacturers after the tariff hike is imposed.
Who is potentially the biggest winner in Malaysia? Capacity matters.
- Read more at SGinvestors.io.
Above is the excerpt from report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full report in PDF @ https://www.utrade.com.sg/.
Jack Goh UOB Kay Hian Research | https://research.uobkayhian.com/ 2024-09-17
Read also UOB's most recent report:
2024-06-20 Top Glove - 3QFY24 Turning Over A New Leaf .
Previous report by UOB:
2024-03-21 Top Glove - A Setback In 2QFY24 With Silver Linings .
Price targets by 2 other brokers at Top Glove Target Prices.
Listing of research reports at Top Glove Analyst Reports.
Relevant links:
Top Glove Share Price History,
Top Glove Announcements,
Top Glove Dividends & Corporate Actions,
Top Glove News Articles
